Abstract:Key PointsCRISPR–Cas (clustered regularly interspaced short palindromic repeats–CRISPR-associated proteins) is an adaptive immune system in bacteria and archaea, which is categorized into three distinct types (known as type I, type II and type III) that differ in their compositions and mechanisms of action. Adaptive immunity occurs in three distinct stages: acquisition, expression and interference.In all three types of CRISPR–Cas system, spacer acquisition relies on a pair of conserved Cas proteins (Cas1 and Cas2), which are probably assisted by a variable set of additional (potentially both Cas and non-Cas) enzymes.Primary processing of CRISPR RNAs (crRNAs) is catalysed either by Cas6-like ribonucleases (in the type I and type III systems) or by RNase III (which targets the crRNA and transactivating crRNA (tracrRNA) duplex in type II systems).Mature crRNAs form CRISPR ribonucleoprotein (crRNP) complexes by associating with either Cascade-like multiprotein complexes (in type I and type III systems) or the multidomain Cas9 protein (in type II systems).Discrimination of 'self' nucleic acid from 'non-self' nucleic acid enables crRNP complexes to specifically target invading nucleic acid (usually DNA). Some complexes recruit additional nucleases (for example, Cas3 in type I systems), whereas other crRNPs have intrinsic nuclease domains (for example, Cas9 in type II systems).Fundamental studies have elucidated many mechanistic features of CRISPR–Cas functionality by integrating genetics, biochemistry and structural biology. This has provided an excellent basis for developing a wide range of applications, from the manipulation of gene expression in bacteria to genome editing in eukaryotes.

Structures of the Cmr-β Complex Reveal the Regulation of the Immunity Mechanism of Type III-B CRISPR-Cas

Coupling of ssRNA cleavage with DNase activity in type III-A CRISPR-Csm revealed by cryo-EM and biochemistry

Cmr1 enables efficient RNA and DNA interference of a III-B CRISPR–Cas system by binding to target RNA and crRNA

Københavns Universitet Cmr 1 enables efficient RNA and DNA interference of a IIIB CRISPR – Cas system by binding to target RNA and crRNA

Structure Studies of the CRISPR-Csm Complex Reveal Mechanism of Co-transcriptional Interference

Structural and functional insights into the type III-E CRISPR-Cas immunity

Structure and function of a bacterial type III-E CRISPR–Cas7-11 complex

Target Preference of Type III-A CRISPR-Cas Complexes at the Transcription Bubble.

Structural insights into the CRISPR-Cas-associated ribonuclease activity of Staphylococcus epidermidis Csm3 and Csm6

Unravelling the structural and mechanistic basis of CRISPR–Cas systems

Structural basis for the endoribonuclease activity of the type III-A CRISPR-associated protein Csm6

RNA activation‐independent DNA targeting of the Type III CRISPR‐Cas system by a Csm complex

Structural insight into the Csx1-Crn2 fusion self-limiting ribonuclease of type III CRISPR system

RNA targeting and cleavage by the type III-Dv CRISPR effector complex

Cryo-EM structure and protease activity of the type III-E CRISPR-Cas effector

Target DNA recognition and cleavage by a reconstituted Type I-G CRISPR-Cas immune effector complex

Structural basis for the non-self RNA-activated protease activity of the type III-E CRISPR nuclease-protease Craspase

Structure Principles of CRISPR-Cas Surveillance and Effector Complexes

Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR–Cas system

Structural coordination between active sites of a CRISPR reverse transcriptase-integrase complex

Target RNA activates the protease activity of Craspase to confer antiviral defense